Quick Answer
IceCure Medical Ltd. reported Operating Income Loss of -$15.09 million for the year ending 2025.
- IceCure Medical Ltd. showed an increase of +3.8% in Operating Income Loss from 2024 to 2025.
- This data is from IceCure Medical Ltd.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), IceCure Medical Ltd.'s Operating Income Loss has declined by 264.4%.
- Historical annual values: Fiscal year 2025: -$15.09 million | Fiscal year 2024: -$15.70 million | Fiscal year 2023: -$15.58 million | Fiscal year 2022: -$16.74 million | Fiscal year 2021: -$9.72 million | Fiscal year 2020: -$4.14 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: